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Yuguang Shi, Barbara Veit, and Steinunn Bmkkeskov 
Departments of Medicine, and Microbiology and Immunology, and Hormone Research Institute, University of California, San 
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Abstract. The smaller isoform of the GABA syn- 
thesizing enzyme glutamic acid decarboxylase, GAD65, 
is synthesized as a soluble protein that undergoes post- 
translational modification(s) in the NH2-terminal re- 
gion to become anchored to the membrane of small 
synaptic-like microvesicles in pancreatic B cells, and 
synaptic vesicles in GABA-ergic neurons. A soluble 
hydrophilic form, a soluble hydrophobic form, and a 
hydrophobic firmly membrane-anchored form have 
been detected in/5 cells. A reversible and hydroxyl- 
amine sensitive palmitoylation has been shown to dis- 
tinguish the firmly membrane-anchored form from 
the soluble yet hydrophobic form, suggesting that 
palmitoylation of cysteines in the NH2-terminal region 
is involved in membrane anchoring. In this study we 
use site-directed mutagenesis to identify the first two 
cysteines in the NH2-terminal region, Cys 30 and Cys 
45, as the sites of palmitoylation of the GAD65 mole- 
cule. Mutation of Cys 30 and Cys 45 to Ala results in 
a loss of palmitoylation but does not significantly alter 
membrane association of GAD65 in COS-7 cells. Dele- 
tion of the first 23 amino acids at the NH2 terminus of 
the GAD~30/45A mutant also does not affect he 
hydrophobicity and membrane anchoring of the GAD65 
protein. However, deletion of an additional eight 
amino acids at the NH2 terminus results in a protein 
which is hydrophilic and cytosolic. The results uggest 
that amino acids 24-31 are required for hydrophobic 
modification and/or targeting of GAD65 to membrane 
compartments, whereas palmitoylation of Cys 30 and 
Cys 45 may rather serve to orient or fold the protein 
at synaptic vesicle membranes. 
F 
ILEXIBLE membrane association is an important fea- 
ture of several proteins involved in membrane traf- 
ticking and intracellular signaling (Fischer et al., 
1990; Magee t al., 1987; Pate Skene and V'n~g, 1989; Levis 
and Bourne, 1992). It is also a characteristic of some en- 
zymes involved in the biosynthesis of neurotransmitters. 
Thus glutamic acid decarboxylase, the smaller form of 
the -t-amino butyric acid (GABA) synthesizing enzyme glu- 
tamic acid decarboxylase, GADS*, 1 (Christgau et al., 1991, 
1992), tyrosine hydroxylase, the initial and rate limiting en- 
zyme in the synthesis of catecholamines (Kuhn et al., 1990), 
and dopamine &hydroxylase, the final enzyme in the synthe- 
sis of norepiuephrine (Bon et al., 1991), share flexible mem- 
brane anchoring to secretory vesicles that store and release 
their neurotransmitter, suggesting an important regulatory 
role of membrane localization. 
Address all correspondence to S. Bmkkeskov, Hormone Research Institute, 
University of California, San Francisco, 513 Parnassus Avenue, Room 
HSW 1090, San Francisco, CA, 94143-0534. 
1. Abbreviations used in this paper:, aa, amino acid; GABA, T-amino butyric 
acid; GAD, glutamic acid decarboxylase; MHC, major histocompatibility 
complex; PLP, pyridoxal Y-phosphate; wt, wild-type. 
GAD is encoded for by two distinct non-allelic genes, 
GAD6~ and GADS*, which are probably derived from a 
common ancestor gene and share significant homology ex- 
cept in the first 95 amino acids (Erlander et al., 1991). Both 
proteins are synthesized inthe cytoplasm as hydrophilic and 
soluble molecules, and GAD67 remains in this form. GADS* 
is posttranslationally modified and becomes anchored to the 
membrane of small synaptic-like microvesicles (Christgau et 
al., 1991, 1992). The two GAD proteins appear to comprise 
a dual system for GABA synthesis (Erlander et al., 1991). 
GADs7 is tightly associated with the coenzyme pyridoxal 
5"phosphate (PLP), and may be responsible for constitutive 
production of GABA. A significant fraction of GADS* is de- 
tected as the apoenzyme and is PLP inducible. Thus activa- 
tion of GADs, can be regulated by PLP levels, and this 
form may be responsible for generation of GABA in situa- 
tions of sudden increases in GABA demand (Martin et al., 
1991). The membrane localization of GADs  may facilitate 
delivery of GABA directly to a synaptic vesicle or synaptic 
like microvesicle for rapid accumulation and secretion. In 
contrast GABA synthesized by GAD67, if destined for reg- 
ulatory secretion, has to be transported from the cytosol and 
taken up by synaptic vesicles. 
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The GAD65 protein is unusually susceptible to becoming 
a target ofautoimmunity that affects its major sites of expres- 
sion, pancreatic B cells and GABA-ergic neurons. Thus 
GAD~ is a major target antigen in both Type 1 diabetes, 
which results from an autoimmune destruction of/~ cells 
(Beekkeskov et al., 1990; Tisch et al., 1993; Kaufman et al., 
1993), and in stiff-man syndrome which affects GABA-ergic 
neurons (Solimena et al., 1990). In contrast, GAD67 does 
not seem to play an independent role as an autoantigen. 
Rather, GAD67 appears to be recognized only when the im- 
mune response to GADs5 involves cross-reacting epitopes 
in the two proteins (Velloso et al., 1993; Hagopian et al., 
1993; SeiBler et al., 1993). We have proposed that he mem- 
brane anchoring of GAD65 to a secretory vesicle is of sig- 
nificance for the presentation f this form to the immune sys- 
tem and its selective role as an autoantigen (Christgau et al., 
1992). 
The posttranslational membrane anchoring of GAD65 in- 
volves at least two steps. The first step is irreversible and 
results in a hydrophobic molecule which is still mainly local- 
ized in .the cytosol. The second step is reversible and results 
in a firm membrane anchoring of the protein (Christgau et 
al., 1991). The soluble and membrane associated forms of 
GAD65 show identical ocation on two-dimensional gels, 
suggesting that they are distinguished by small noncharged 
lipid moieties (Christgau et al., 1991). The modifications of
GADs5 do not seem to involve polyisoprenylation, myris- 
toylation, or a phosphatidylinositol glycan. However, palmi- 
toylation distinguishes the membrane-associated nd soluble 
forms of GADs, suggesting that this fatty acid is involved 
in membrane anchoring (Christgau et al., 1992). GADs5 
has a proteolytic hot spot 69-80 amino acids into the mole- 
cule. Trypsin cleavage at amino acid (aa) 69 or 70 results in 
a soluble hydrophilic COOH-terminal fragment and a small 
membrane bound palmitoylated fragment, demonstrating 
that the NH2-terminal region is the site of lipid modifica- 
tion and membrane anchoring of GAD65 (Christgau et al., 
1992). Consistent with this result, a hybrid molecule con- 
taining the NH:-terminal 1-83 amino acids of the GAD65 
molecule and amino acids 89-593 from GAD67 is mem- 
brane associated (Solimena et al., 1993). 
In this study we have analyzed the structural requirements 
of palmitoylation of GAD~ and assessed its role in mem- 
brane anchoring. Our results suggest hat palmitoylation 
does not play the major role in membrane anchoring of 
GADa. Rather a small segment of amino acids adjacent to 
the palmitoylation sites is required for targeting and mem- 
brane anchoring of GAD65. 
Materials and Methods 
Generation of GAD,~ Mutants 
A 2.4-kb eDNA clone of rat GAD65 (a gill from Dr. A. "robin, University 
of California, Los Angeles, CA) was used in this study (Erlander and Tobin, 
1991). The eDNA carded the entire coding region and 80- and 400-bp 5' 
and 3' untranslated sequences, respectively, and was originally cloned into 
the EcoRI site of the Blueseript vector (Stratagene, La Jolla, CA). The se- 
quence spanning the first AUG was altered to match the Kozak consensus 
sequence for optimum translation efficiency (Kozak, 1991) by site directed 
in vitro mutagenesis. The resulting plasmid was named pBL-YS10. Oli- 
gonucleotide-mediated in vitro mntagenesis was carried out according to 
Kunkel (1987). Sequencing of mutant DNA with Sequenase (Boehringer 
Marmheim Corp., Indianapolis, IN) was carried out using protocols 
provided by the manufacturer. The wild-type eDNA with a Kozak sequence 
was subcloned from pBL-YS10 into the KpnI and Notl sites of the expression 
vector pSV-SPORT (GIBCO BRL, Gaithersburg, MD). The resulting plas- 
mid was named pSV-YS10 (see Fig. 2, WT). Amino acid substitution mu- 
• rants were generated bychanging Cys to Ala or Ser residues using pBL-YS10 
as template DNA. The resulting mutant DNAs were subcloned into the Not/ 
and HindIIl sites of the pCDM8 vector (Seed and Aruffo, 1987) or KpnI 
and XbaI sites of the pSV-SPORT vector. Expression vectors that carry Cys 
to Ala substitutions were pCDM-YS17 (see Fig. 2 A, Cys 30 to Ala, 30A), 
pCDM-YS35 (see Fig. 2 A, Cys 45 to Ala, 45A), and pSV-YS17/35 (see Fig. 
2 A, Cys 30 and Cys 45 to Ala, 30/45A). The expression vectors that carry 
Cys to Ser substitutions were pCDM-YS1 (see Fig. 2 A, Cys 73 to Ser, 73S), 
pCDM-YS2 (see Fig. 2 A, Cys 75 to Ser, 75S), pCDM-YS3 (see Fig. 2 A, 
Cys 73 and Cys 75 to Ser, 73/75S), pCDM-YS4 (see Fig. 2 A, Cys 80 to 
Ser, 80S), pCDM-YS5 (see Fig. 2 A, Cys 82 to Ser, 82S), pCDM-YS6 (see 
Fig. 2 A, Cys 80 and Cys 82 to Ser, 80/82S), pCDM-YS39 (see Fig. 2 A, 
Cys 75, Cys 80, and Cys 82 to Ser, 75/80/82S), and pCDM-YS8 (see Fig. 
2 A, Cys 101 to Ser, 10IS). Plasmid pMT-YSll carried an insertion of a 
eDNA fragment lacking the NH2-terminal 101 amino acids at the EcoRI 
site of the expression vector pMT2 (a kind gill from R. J. Kaufman, 
Genetics Institute, Cambridge, MA). The deletion fragment was generated 
by oligonueleotide-directed mutagenesis bychanging the Cys 101 into the 
first AUG codon flanked by a Kozak consensus sequence (Kozak, 1991) and 
an EcoRI site 5' to the consensus sequence. 
Expression plasmids for wild-type and mutant p21H-ras (181/4S) were 
kindly donated by Dr. J. Hancock (Onyx, Emeryville, CA) (Hancock et al., 
1990). 
Generation of Deletion Mutants by PCR 
Systematic deletions of the amino terminus of the rat GAD~ 30/45A mu- 
tant were generated by polymerase chain reactions (PCRs) using anchored 
primers. The 5' primers carded an overhang containing the Kozak con- 
sensus equence (Kozak, 1991), and the 3' primers carried an overhang con- 
raining a translation termination codon. The 5' and 3' primer also carried 
a KpnI site upstream from the Kozak consensus sequence and an XbaI site 
downstream of the termination codon to facilitate unidirectional insertion 
of the amplified expression cassette into the KpnI and XbaI sites of the COS 
expression vector pSV-SPORT. Plasmid pCDM-YS17/35 was used as tem- 
plate DNA. The high fidelity Pill thermostable DNA polymerase 
(Stratagene) was used to minimize the rate of mismatches in the amplifica- 
tion reaction. 
Sequencing of the deletion mutants was carded out with an automated 
sequencing apparatus (Applied Biosystems, Inc., Foster City, CA). The de- 
letion fragments were subeloned into the KpnI and BgllI sites of the expres- 
sion vector pSV-YS10 replacing the first 357 amino acids of GAD~ with a 
deleted NH2-terminal region. Expression vectors that carry the NH2- 
terminal deletions were pSV-YS63, A1-8; pSV-YS64, Al-15; pSV-YS65, A1- 
23; pSV-YS66, A1-31; pSV-YS67, A1-38 (Fig. 2 B). 
Culture of CeUs and Transfection 
For transient transfection, COS-'/cells were seeded on 60-mm petri dishes 
and cultured for 15-24 h to 60-70% confluency. The cells were transfected 
using DOTAP (Boehringer Mannheim Corp.) by adding 100/zl mixture con- 
taining 5 pg DNA and 25 ~1 DOTAP in transfecfion buffer (20 mM 
Hepes/NaOH, pH 7.4, 150 mM NaCI). Transfected coils were refreshed af- 
ter 12-18 h and incubated for additional 48 h before biosynthetic labeling 
and immunoprecipitation studies or harvesting for subcollular fraetionation 
and/or Triton X-I14 partition studies. 
Antisera 
The antisera used in this study included two rabbit polyelonal antisera, 1266 
and 1267, and two mouse monoelonal ntibodies, GAD6 and Ab-1. The 
1266 and 1267 antisera (a gilt from J. S. Petersen, Hagedorn Research Lab- 
oratory, Gentolle, Denmark) and the 1701 serum were raised in rabbits 
against a synthetic peptide containing the last 19 amino acids of the COOH- 
terminal region of GAD67. These antisera recognize GAD~ and GAD67 
equally well on western blots (Kim et al., 1993). The GAD6 monoclonal 
antibody (Chang and Gottlieb, 1988) (a gift from Dr. D. Gottlieb, Washing- 
ton Universivy, St. Louis, MO) is specific for GAD~ (Kim et al., 1993). 
Monoelonal antibody Ab-1 against p21H-'~ was from Oneogene Science 
Inc. (Uniondale, NY). 
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Biosynthetic Labeling and lmmunoprecipitation 
For labeling with [35S]methionine, c lls were washed twice in methionine 
free DME medium and incubated for 4 h in 2.5 ml of the same medium 
supplemented with 100 ILCi [35S]methionine, 1% fetal calf serum, 100 
U/ml penicillin, and 100/~g/ml streptomycin. For labeling with [3H]pal- 
mitic acid, cells (106 in a 60-mm petri dish) were washed twice in DME, 
followed by incubation for 4 h in 2.5 ml of DME supplemented with 0.5 
mCi [3H]palmitic acid, 1% fetal calf serum, 100 U/ml penicillin, 100 
/~g/ml streptomycin, 2 mM glutamine, nonessential amino acids (50 #M al- 
anine, 100 ttM each of asparagine, aspartic acid, glutamic acid, glycine, 
proline, and serine), and 5 mg/ml fatty acid free bovine serum albumin. Af- 
ter labeling, cells were washed once in ice cold DME, then twice in cell 
harvesting buffer (20 mM Hepes/NaOH, pH 7.4, 150 mM NaCI, 10 mM 
benzamidine/HC1). Washed cellswere extracted in 0.5 ml hypotonic Hepes 
buffer (10 mM Hepes/NaOH, pH Z4, 1 mM MgCI2, 1 mM amino- 
ethylisothiouronium bromide hydrobromide, 0.2 mM PLP, 1 mM PMSF 
containing 1% Triton X-114), followed by centrifugation to remove insolu- 
ble debris. The soluble xtracts (500 p.l) were subjected to immunoprecipi- 
tation analysis. Immunoprecipitation of labeled GAD65 proteins was per- 
formed as described previously by Christgau et al., (1991, 1992) using the 
monoclonal ntibody GAD6 for GAD65 and its point mutants, and antise- 
rum 1266 for deletion mutant pMT-YS11. Before immunoprecipitation with 
the 1266 antiserum, the cell extract was supplemented with 0.1% SDS. Im- 
munoprecipitates were analyzed by 10% SDS-PAGE and fluorography 
(Beekkeskov et al., 1989). 
Subcellular Fractionation 
Transfected COS 7 cells from a 6-cm petri dish (106) were washed twice 
with phosphate buffered saline and homogenized at 4"C in 0.5 ml of hypo- 
tonic Hepes buffer containing 1mM Na3VO4. The homogenate was cen- 
trifuged at 800 g for 10 min at 4"C to pellet he nuclei. The postnuclear 
supernatant was centrifuged at100,000 g for 1 h to separate cytosol (S) and 
particulate fractions. The resulting pellet was resuspended and incubated 
for 1 h at room temperature with membrane washing buffer (10 mM 
Hepes/NaOH, pH 7.4, 0.5 M NaC1, 0.1 mM p-chloromercuriphenyl sul-
fonic acid, 5 mM EDTA, 0.25% trasylol, 5 mM NaF, 10 mM benzami- 
dine/HC1, 0.1 mM Na3VO4, 0.2 mM PLP, 3 mM PMSF), followed by 
ultracentrifugation at 100,000 g for 1 h to pellet he washed membranes. 
Washed membranes were extracted for 2 h at 4°C with hypotonic Hepes 
buffer containing 1% Triton X-114 followed by centrifugation for 45 rain at 
100,00(3 g to separate the particulate extract (P) from insoluble debris. The 
cytosol proteins and proteins extracted from washed membranes were sub- 
jected to Triton X-I14 partition assays. 
Triton X-114 partitioning assays were performed on the subeellular frac- 
tions described above or on Triton X-114 detergent extracts of total cells, 
using a modification of the procedure of Bordier (1981). For comparative 
analyses of the amphiphilic properties of GAD65 in subcellular f actions, 
buffer compositions were adjusted to achieve identical conditions in each 
fraction. Triton X-114 phase transition of each fraction was induced by incu- 
bation at 37"C for 2 rain. Aqueous (A) and detergent (D) phases were sepa- 
rated by centrifugation at 12,000 g for 2 min. The detergent and aqueous 
phases were analyzed by 10% SDS-PAGE followed byimmunoblotting ac- 
cording to Christgau et al. (1991, 1992) using antiserum 1266 or 1267 (dilu- 
tion 1:1,000) for GAD65 and its mutant proteins and Ab-1 (dilution 1:500) 
for p21H~ and its mutant proteins. 
Results 
Palmitoylation and Membrane Anchoring Are Intrinsic 
Properties of the NHrterminal Region of GADtj 
Analyses of trypsin fragments of GAD65 have suggested that 
palmitoylation and membrane anchoring reside in a small 
NH2-terminal fragment of GAD65 (Christgau et al., 1992). 
To confirm this finding, a NH2-terminal deletion mutant of 
GAD65, lacking the first 101 amino acids (GAD~AI-101), 
was generated and analyzed for its palmitoylation and mem- 
brane anchoring properties by transient expression i  COS-7 
cells. Wild-type (wt) GAD65 incorporates [3H]palmitic acid 
in COS-7 cells (Fig. 1, lane 1 ) and becomes membrane an- 
chored. In contrast the GAD~AI-101 mutant is not pal- 
mitoylated (Fig. 1, compare lanes 5 and 10). Furthermore, 
immunoblotting analysis of soluble and particulate frac- 
tions isolated from transfected COS-7 ceils detected the 
GAD~AI-101 protein exclusively in soluble fractions (re- 
suits not shown). Those results provide strong evidence that 
palmitoylation and membrane anchoring is mediated by the 
NH2-terminal 101 amino acids of GAD65. 
Site-directed Mutagenesis ofCys 30 
and Cys 45 Abolishes Palmitoylation of
the GADo Molecule 
The palmitoylation in the NH2-terminal domain of GAD~ 
is hydroxylamine sensitive suggesting a thioester linkage 
(Christgau et al., 1992). To localize the site(s) of palrnitoyla- 
Immunofluorescence Analyses 
COS cells eeded in cover slips were cultured to 60-70% confluency before 
transfection with a GAD65 expression construct or a control plasmid. 20 h 
later the ceils were processed for immunofluorescence analysis. Eachma- 
nipulation was preceded by washing of cells three times in PBS. Cells were 
fixed in methanol for 5 rain at -20°C, before incubation i blocking buffer 
(PBS, 2.5% fetal bovine serum, 0.02% azide) for 10 rain at room tempera- 
rare. The cells were incubated with the 1701 antiserum (diluted 1:500 in
blocking buffer) for 30 rain at room temperature followed by incubation 
with a secondary antibody (rhodamine conjugated goat anti-rabbit antise- 
rum; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) diluted 
1:100 in blocking buffer. After the final wash, the cover slips were inverted 
onto slides with mounting medium (1 mg/ml phenylenediamine i  10 mM 
Tris-HC1 pH 8.5, 90% glycerol), sealed with nail polish, and observed 
through aZeiss Axiophot microscope (Carl Zeiss, Inc., Thornwood, NY). 
Figure 1. Site-directed mutagenesis of Cys 30 and Cys 45 abolishes 
palmitoylation in GAD65. SDS-PAGE of wt GADts and mutant 
proteins labeled with [3H]palmitic acid or [35S]methionine. COS-7 
cells transiently expressing wt GAD65, or the 30A, 45A, Al-101, 
and 30/45A mutant proteins were labeled with either [3H]palmitic 
acid (lanes 1-5) or [3SS]methionine (lanes 6--10) and immunopre- 
cipitated with either the GAD6 antibody (lanes 1-4 and 6-9) or the 
1266 antiserum (lanes 5 and 10). 30A: replacement of Cys 30 with 
Ala; 45A: replacement of Cys 45 with Ala; AI-101: deletion of the 
NH2-terminal 101 amino acids; 30/45A: replacement of both Cys 
30 and Cys 45 with Ala. To obtain similar intensity of radioactive 
proteins on fluorograms, the ratio between immunoprecipitated 
[35S]methionine and [3H]palmitic acid-labeled proteins ubjected 
to SDS-PAGE was 1:40. 
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Figure 2. Sequence of Cys substitution mutants and NH2-terminal 
deletion mutants of GAD65. (A) Mutations of cysteine residues in 
the NH2-tenninal region of GADs. The wt GAD6s sequence is 
given at the top with the positions of the cysteines to be mutated 
given in bold face. The substitutions for these cysteines areindi- 
cated for each mutant. The dashed lines denote amino acids which 
are identical in wtand mutant proteins. (B) NH2-terminal dele- 
tions of the GAD¢30/45A mutant. Thewild-type sequence is indi- 
cated at the top. The dashed lines indicate amino acids which are 
identical in wt and mutant protein. None of the deletion mutants 
carry the palmitoylation sites (Cy  30 and Cys 45). An additional 
substitution fPhe to Val was introduced into the AI-8 deletion mu- 
tant to generate a Kozak DNA consensus sequence for translation 
efficiency (Kozak 1991). 
don and to investigate he role of this fatty acid in membrane 
anchoring, cysteine residues in the NH2-terminal region 
were systematically substituted by alanine or serine residues 
using site directed in vitro mutagenesis (Fig. 2 A). The sub- 
stitution mutants were transiently expressed in COS-cells 
and analyzed for incorporation of [~H]palmitic acid in bio- 
synthetic labeling experiments. All of the single cysteine 
substitution mutants incorporated [3H]pahnitic acid (not 
shown). Analyses of a series of mutants containing substitu- 
tions of combinations of two and three cysteines in the 
NH2-terminal region (Fig. 2 A) identified one mutant hat 
had lost the ability to incorporate [3H]palmitic acid (Fig. 1, 
lane 4). All the other combinations ofdouble and triple cys- 
teine mutations shown in Fig. 2 A incorporated palmitic acid 
(not shown). In the non-palmitoylated mutant (30/45A) Cys 
30 and Cys 45 were replaced byalanine. The result suggests 
that Cys 30 and Cys 45 are the sites of posttranslational 
palmitoylation i GADts. 
Non-palmitoylated Form f GAD~ 
Remains Hydrophobic and Membrane Bound 
in COS-7 Cells 
To investigate the effect of loss of palmitoylation on the 
hydrophobicity of GAD¢, Triton X-114 extracts of COS-7 
cells expressing either wt GAD~ or the 30/45A mutant 
were subjected to temperature induced Triton X-114 phase 
transition. The detergent and aqueous phases were separated 
Figure 3. Partition of GADs, GAD~30/45A and deletion mutants 
of GAD6530/45A into Triton 3[-114 detergent phase. Triton X-lI4 
total cell extracts ofCOS-7 cells expressing the indicated mutants 
were subjected to temperature induced phase separation and the 
aqueous (,4) and detergent (/9) phases analyzed by SDS-PAGE and 
immunohlotting using the 1267 antiserum, which recognizes the 
COOH terminus of GAD. 
and analyzed by immunoblotting (Fig. 3). These analyses 
showed that the 30/45A mutant partitioned into the Triton 
X-114detergent phase at a similar ratio as the wt protein 
(Fig. 3, compare lanes 1 and 2 with lanes 13 and 14) demon- 
strafing that he non-palmitoylated 30/45A mutant is still am- 
phiphilic. This result is consistent with the finding that 
palmitoylation is not the first step in the posttranslational hy- 
drophobic modification of GAD~,, but rather a subsequent 
step that distinguishes the hydrophobic soluble form, which 
has undergone the first modification, from a hydrophobic 
membrane anchored form (Christgau et al., 1991, 1992). 
To assess the role of palmitoylation i  membrane anchor- 
ing of the GAD65 molecule, we analyzed the subcellular 
distribution of wt and the non-palmitoylated GADs30/ 
45A mutant expressed in COS-7 cells. The distribution of 
GADe in those experiments was compared with wt and a 
non-palmitoylated mutant of p21 "-'~' which were co-trans- 
letted into COS-7 cells and analyzed in parallel. 
Palmitoylation of Cys 181 and Cys 184 in p21H-'- is re- 
quired for membrane anchoring and mutation of these 
residues to serines (p21"-'~lSlf184S) abolishes membrane 
anchoring (Hancock et al., 1990). COS-7 cells co-trans- 
fected with either wt GADe and wt p21 "-'~ (Fig. 4, lanes 
1-4) or GAD~30/45A and p21H"~lSI/184S (Fig. 4, lanes 
13-16) were homogenized and separated into a cytosol and 
a particulate membrane fraction. The membrane fraction 
was washed in 0.5 M NaC1. Proteins in the cytosolic and 
washed membrane fractions were subjected to Triton X-114 
phase separation. The distribution of wt and non-palmitoy- 
lated mutants of GADs, and p21H-'~ into the detergent and 
aqueous phases of each fraction was analyzed by immuno- 
blotting. The results of these analyses are shown in Fig. 4, 
lanes 1-4 and 13-16. 
p21H-~ is synthesized as a hydrophilic soluble molecule 
(Fig. 4, lanes I and 13) and undergoes a two step posttransla- 
tional modification at its carboxyl terminus to become mem- 
brane anchored. The first step involves farnesylation ofCys 
The Jourlla] of Cell Biology, Volume 124, 1994 930 
Figure 4. Suboellular distribution of GADs, GADs30/45A, and 
deletion mutants of GADs30/45A in COS-'/ cells. A cytosolic 
fraction (S) and an extract of a washed membrane fraction (P) were 
prepared from COS-'/cells expressing the indicated proteins and 
subjected to Triton X-I14 phase separation. W'tld-type 1)21H-'~ was 
co-expressed with wt GADs (lanes 1-4) and the GAD~30/45A~l- 
31 mutant (lanes 5-8). The non-palmitoylated ras mutant 181/184S 
was co-expressed with the GAD6530/45A~l-38 (lanes 9-12) and 
GAD6530/45A (lanes 13-16). Aqueous (,4) and detergent (D) 
phases were analyzed by SDS-PAGE and immunoblotting with the 
antiserum 1267 for GADs and its mutants and antiserum Ab-1 for 
p21H-'~ and its mutants. Arrows indicate the position of the GAD 
and ras proteins. The wild-type ras is detected as an immature cyto- 
solic form present o ly in the aqueous phases (lanes I and 5) and 
as the fully modified farnesylated and palmitoylated membrane an- 
chored form detected exclusively in the detergent phase (lanes 4 and 
8). In the 181/184S mutant of ras, the palmitoylation sites (Cys 181 
and Cys 184) are mutated to serine. Lack of palmitoylation abol- 
ishes membrane anchoring and hence this mutant accumulates as 
the immature hydrophilic and cytosolic form (lanes 9 and 13 ) and 
as a farnesylated, hydrophobic but soluble form (lanes 10 and 14). 
In contrast, lack ofpalmitoylation fthe GAD65 protein does not 
result in a significant change in membrane anchoring or distribution 
between aqueous and detergent phases (compare lanes 1-4 with 
lanes 13-16). However deletion f amino acids 1-31 and 1-38 in 
the non-palmitoylated GADs30/45A mutant result in hydrophilic 
mutant proteins predominantly located in the cytosol. 
186, proteolytic removal of the last three amino acids and 
carboxyl methylation of the Cys 186 carboxyl terminus 
(Hancock et al., 1989; Schafer et al., 1989; Casey et al., 
1989; Gutierrez et al., 1989). The farnesylated form of ras 
is hydrophobic and cytosolic. The second step involves are- 
versible palmitoylation of Cys 181 and Cys 184 and results 
in a firmly membrane anchored protein (Hancock et al., 
1989) (Fig. 4, lane 4). In the p21H-'~181/184S mutant mem- 
brane anchoring is abolished (Hancock et al., 1990) and the 
farnesylated form of p21 x-~ accumulates (Fig. 4, lane 14). 
In COS-7 cells, as in pancreatic/3 cells, wt GADs pro- 
tein is detected inboth cytosol and membrane fractions, con- 
sistent with its presence in both soluble and membrane an- 
chored forms (Fig. 4, lanes 1-4; Christgau et al., 1991, 
1992). In both cytosolic and membrane fractions the wt 
GAD~ protein distributes into the Triton X-114 detergent 
phase consistent with the hydrophobic soluble and hydropho- 
bic membrane anchored forms demonstrated for this protein 
(Christgau et al., 1991, 1992). The hydrophobic GADs 
forms, in contrast o the p21H-'~ forms, never partition 
completely into the detergent phase but are consistently de- 
tected in both aqueous and detergent phases (Christgau et 
al., 1991, 1992). It is likely that the size of GADs 
precludes its quantitative partitioning into the detergent 
phase (Bjerrum et al., 1983). The majority of the wt GADs 
protein is however found together with the wt 1)21H-'~ protein 
in the detergent phases of the membrane fraction (Fig. 4, 
lane 4). The GADs30/45A mutant behaved similarly to the 
wt protein in those analyses (Fig. 4, compare lanes 1-4 with 
13-16). Thus a significant fraction of the non-palmitoylated 
mutant protein was found in membrane fractions where it 
distributed into the Triton X-114 detergent phase (Fig. 4, 
lane 16). In comparison, the p21a~181/184S mutant was 
found exclusively in the cytosol fraction. Thus in contrast to 
p21H-'% palmitoylation of the GADs protein is not a requi- 
site for membrane anchoring. Instead other modification(s) 
in the NH2-terminal region are implied. Those results moti- 
vated an investigation ofwhich part of the NH2-terminal re- 
gion is required for hydrophobic modification of membrane 
anchoring of GADs. 
Amino Acid Residues 24-31 Are Essential for 
Membrane Anchoring of GADtj 
To further localize the sequences in the NH2-terminal re- 
gion which are required for targeting and anchoring of 
GADs to membrane compartments, we analyzed the effect 
of stepwise deletions of NH2-terminal sequences in the 
GAD~30/45A mutant on the hydrophobicity and membrane 
anchoring of the resulting proteins (Fig. 2 B). The mutants 
were transiently expressed in COS-7 cells and analyzed in 
Triton X-114 partition assays (Fig. 3), in parallel with wt 
GAD65 and the 30/45A mutant from which they were de- 
rived. Deletions of up to 23 NH2-terminal amino acids of 
the 30/45A mutant did not result in significant changes in 
hydrophobicity of the resulting proteins (Fig. 3, compare 
lanes 3-8 with lanes 1-2). However, deletion of an additional 
eight amino acids (A1-31) resulted in a protein which did not 
partition into the Triton X-114 detergent suggesting that this 
protein does not undergo hydrophobic modifications and 
hence remains hydrophilic. This mutant protein was ex- 
pressed at lower levels than the shorter deletion mutants 
(Figs. 3 and 4) suggesting that it is less stable than the other 
mutants. However deletion of an additional seven amino 
acids (A1-38) resulted in a protein which was expressed at 
similar levels as the shorter deletion mutants. The A1-38 mu- 
tant also did not partition into the Triton X-114 detergent 
phase demonstrating that it does not undergo hydrophobic 
modification and therefore remains hydrophilic (Fig. 3). 
Analyses of subcellular distribution of the deletion mutants 
in COS-7 cells confirmed that both the A1-31 and A1-38 mu- 
tants were hydrophilic and predominantly localized in the 
eytosol fraction (Fig. 4, lanes 5 and 9). In conditions (wash 
of membrane fraction in 0.5 M NaC1) where all of the non- 
palmitoylated but farnesylated p21 "-'~ 181/184S protein was 
localized in the eytosolic fraction (Fig. 4, lane 10), a small 
fraction of the non-palmitoylated and hydrophilic A1-31 and 
A1-38 GADs was detected in the aqueous phase of the 
membrane fraction (Fig. 4, lanes 7 and 11 ). Thus it appears 
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that the A1-31 and A1-38 deletion mutants maintain a low 
level of membrane avidity in the absence of post-translational 
hydrophobic modification(s) perhaps by association with a 
membrane protein. These data show that deletion of amino 
acids 24-31 in the non-palmitoylated GAD65 mutant results 
in a loss of hydrophobic modification and a predominant lo- 
calization in the cytosol. Thus amino acids 24-31 are re- 
quired for hydrophobic modification and appropriate mem- 
brane anchoring of GAD65. 
lmmunofluorescence Analyses of l~ld ~ and 
Mutants of GAD~ in COS-7 Cells 
GADs5 is anchored to the membrane ofsynaptic-like micro- 
vesicles in pancreatic/3 cells (Christgau et al., 1992), but re- 
mains associated with the Golgi apparatus in transfected 
CHO cells (Solimena et al., 1993). We analyzed the subcel- 
lular distribution of wt GAD65, the 30/45A mutant, and the 
A1-38 mutant in COS-7 cells by indirect immunofluores- 
cence. In COS-7 cells wt GAD65 is localized in a large 
membranous perinuclear compartment, and i  punctate like 
structures that may represent membrane vesicles (Fig. 5 a). 
No significant difference was observed between the wt pro- 
tein and the 30/45A mutant (not shown). The A1-38 mutant 
was evenly distributed in a diffuse pattern throughout the 
cytosol (Fig. 5 b), which is similar to the cellular distribu- 
tion of GAD67 (Solimena et al., 1993; and our unpublished 
results). The immunofluorescence analyses of the cellular 
distribution of wt GAD65 and the two mutants are consistent 
with the results from subcellular analyses and confirm that 
the A1-38 deletion mutant is predominantly c tosolic in con- 
trast to the wt protein which is associated with membrane 
compartments. 
Discussion 
The NH:-terminal region distinguishes the two isoforms of 
mammalian glutamate decarboxylase, GAD65 and GAD67, 
and is altogether absent in Drosophila GAD (Erlander et al., 
1991). It is possible that his region has evolved to target the 
two mammalian enzymes to different sub-cellular compart- 
ments. Thus, while the GAD67 protein is localized in the 
cytosolic ompartment, the NH2-terminal region of GAD65 
mediates targeting and anchoring to membranous compart- 
ments in both endocrine (Christgau et al., 1992) and non- 
endocrine cells (Christgau et al., 1992; Solimena et al., 
1993). 
Pulse-chase analyses of GAD65 in pancreatic/~ cells sug- 
gest that the newly synthesized hydrophilic enzyme is first 
modified to become a hydrophobic molecule which is cyto- 
soliC or of a low membrane avidity. This form then under- 
goes a second set of modifications that include a hydroxyl- 
amine sensitive palmitoylation i  the NH2-terminal region. 
These modifications re ult in a firmly membrane-anchored 
molecule which remains membrane anchored in conditions 
that release peripheral membrane proteins (Christgau et al., 
1991). Because palmitoylation is a distinct property of the 
membrane anchored form (Christgau et al., 1992) we previ- 
ously proposed that palmitoylation might be important for 
membrane anchoring of GADs. Palmitoylation is clearly 
required for membrane association of some of the ras pro- 
teins, where mutation of palmitoylated cysteines results in 
loss of membrane anchoring (Hancock et al., 1990). In this 
Figure 5. Immunofluorescence analyses of COS-7 ceils expressing 
GAD65 and the deletion mutant GAD~30/45AA1-38. COS cells 
transfected with wt GAD~ (a) and GAD6530/45AA1-38 (b) cDNAs 
were immunostained with antiserum 1701 followed by visualization 
using a fluorescence conjugated goat anti-rabbit antiserum. The wt 
GADs5 is concentrated in a perinuclear compartment and in small 
punctate like structures (vesicles) in the cytoplasm. The non- 
palmitoylated deletion mutant of GAD65 shows diffuse cytoplas- 
mic staining. 
study we have identified Cys 30 and Cys 45 as the sites of 
palmitoylation in the GAD~ molecule by site-directed 
mutagenesis. Mutation of both of these residues abolishes 
palmitoylation f GAD~ in COS-7 cells. The non-palmitoy- 
lated mutant is still hydrophobic, which is consistent with a 
biosynthetic pathway in which the protein first undergoes an 
irreversible hydrophobic posttranslational modification(s) 
that results in a hydrophobic yet soluble molecule. Surpris- 
ingly, the non-palmitoylated GADo30/45A mutant is still 
membrane anchored in COS-7 cells, demonstrating that 
palmitoylation is not essential for membrane anchoring. Our 
results uggest that he reversible membrane anchoring of the 
GAD~ molecule (Christgau et al., 1992) is not mediated 
exclusively by a palmitoylation-depalmitoylation mecha- 
nism as it is in some of the ras proteins (Magee t al., 1987; 
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Hancock et al., 1989, 1990). Rather GAD65 undergoes ad- 
ditional posttranslational modification(s) that contribute to 
its membrane association. The nature of this modification is 
currently unknown, but our previous work indicates that sev- 
eral lipid modifications known to contribute to membrane 
anchoring, including polyisoprenylation, phosphatidylinosi- 
tolglypidation rmyristoylation, are not involved in anchor- 
ing GAD65 (Christgau et al., 1992). 
Using the palmitoylation minus mutant of GAD65, we 
have dissected the NH2-terminal region by deleting seg- 
ments of the NH2 terminus and analyzing the hydrophobic- 
ity and membrane anchoring properties of the resulting mu- 
tants. The non-palmitoylated mutant lacking amino acids 
1-23 was not significantly different from the wild-type pro- 
tein with regard to hydrophobicity, subceUular localization 
and membrane anchoring. Thus the first 23 amino acids in 
the NH2 terminus of the GADs5 molecule are not required 
for hydrophobic modification, subcellular targeting, and 
membrane anchoring. However, deletion mutants which 
lacked an additional 8 or 15 amino acids, respectively (aa 
24-31, aa 24-38) failed to undergo hydrophobic modifica- 
tion(s) and were predominantly localized in the cytosol. Thus 
it appears that amino acids 24-31 are required for both the 
first hydrophobic modification and the subsequent mem- 
brane anchoring of GAD65, suggesting that those events 
may be closely linked. It is conceivable that the first hydro- 
phobic modification is a prerequisite for the subsequent 
membrane anchoring modification, as is the case for farnesy- 
lation and palmitoylation i  p21H-'~ and p21N-~ (Hancock et 
al., 1989). Alternatively, the first hydrophobic modification 
and the membrane anchoring moiety in GAD~ may be in- 
dependent but spatially linked and thus both affected by dele- 
tion of amino acids 24-31. Mass spectrometric analyses will 
address the question whether the amino acid 24-31 segment 
itself is posttranslationally modified in the wild-type protein. 
It can not be excluded that deletion of amino acids 24-31 
in the GADts protein results in a conformational change 
elsewhere inthe molecule which is incompatible with target- 
ing and anchoring of GAD65 to membrane compartments. It 
is more likely however that he major effect of deletion is lo- 
cal, which would suggest that the palmitoylated Cys 30 and 
Cys 45 residues are adjacent to the additional hydrophobic 
and membrane anchoring moieties in GADs5. 
What is the role of palmitoylation i  GAD65? Our results 
suggest that palmitoylation is not required for membrane an- 
choring of GAD65. One possibility is that palmitoylation 
presents a redundant or alternative membrane anchoring 
moiety in the GAD65 protein perhaps analogous to the situ- 
ation in the a chain of several of the trirneric GTP-binding 
proteins, which are both palmitoylated and myristoylated 
(Linder et al., 1993; Parenti et al., 1993). Alternatively, it 
is possible that palmitoylation of GAD65 adjacent o the 
membrane anchoring region has a different role, which is ap- 
parent in certain other membrane proteins. For example, the 
Vesicular Stomatitis Virus G protein (Rose et al., 1984), 
CD4 (Crise and Rose, 1992), the transferrin receptor (Jing 
and Trowbridge, 1987), and the heavy chain of the human 
class I histocompatibility antigen HLA-B7 (Kaufman et al., 
1984; Ploegh et al., 1981) each are palmitoylated at cysteines 
adjacent to their membrane spanning region. In those pro- 
teins palmitoylation is not necessary for stable membrane 
association. Rather palmitoylation may serve a different role. 
In the transferrin receptor, lack of palmitoylation i creases 
the rate of endocytosis (Alvarez et al., 1990). In the/~2- 
adrenergic receptor, palmitoylation seems to be important 
for coupling to the guanyl nucleotide regulatory protein Gs 
(Moffett et al., 1993). By analogy palmitoylation fCys 30 
and Cys 45 adjacent to the aa 23-31 segment required for 
membrane anchoring of GAD~ may be important for modi- 
fying the orientation or folding of the protein at the mem- 
brane of synaptic vesicles or synaptic like microvesicles. 
Such folding may facilitate protein-protein orprotein-lipid 
interactions and be important for the function of the enzyme. 
We have shown that a 57-kD hydrophilic soluble COOH- 
terminal fragment of GAD65 can be spontaneously released 
from islet cell membranes a  a function of time suggesting 
an enzymatic reactivity that can cleave the protein down- 
stream from the membrane anchoring region (Christgau et 
al., 1992). The 57-kD fragment is detected in islet cell 
(Christgau et al., 1991) and brain extracts (our unpublished 
results) suggesting that this reactivity is present in both tis- 
sues. Thus, in addition to the reversible membrane anchor- 
ing of GAD65, which may confer a flexible and perhaps 
regulated on-off mechanism ofmembrane anchoring, there 
may be a second and irreversible mechanism that can release 
the protein from membrane compartments as a fragment that 
has lost the membrane anchoring domain. 
It is not known whether the reversible targeting of GAD65 
to the membrane ofsynaptic vesicles or synaptic-like micro- 
vesicles plays a role in its presentation to the immune system 
and thus its unique autoantigenicity compared with GAD67. 
It can be hypothesized that reversible anchoring to the mem- 
brane of synaptic vesicles which are part of the endo- 
cytic/exocytic membrane network, and perhaps also the pro- 
teolytic release mechanism described above, targets the 
protein for increased egradation a d presentation byMHC 
class I antigens for recognition by cytotoxic T-ceils. Alterna- 
tively, the membrane-anchored GAD65 may be targeted to 
the surface during exocytosis for recognition by autoanti- 
bodies. Whereas the first mechanism appears relevant for 
T-cell-mediated destruction ofpancreatic/~ cells, the second 
possibility may be the only mechanism by which GABA- 
ergic neurons can present the protein to the immune system 
in the absence of MHC class I antigen expression. 
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